Insulin, Regular, Human: Clinical Trials

10 trials of Insulin, Regular, Human, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 terminated, 4 completed, 1 withdrawn. 10 Phase 2, 6 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 210Terminated 5, Completed 4, Withdrawn 1
Phase 36Terminated 5, Withdrawn 1

Follow Insulin, Regular, Human: new trials by email Literature Review of Insulin, Regular, Human trials Research Report on Insulin, Regular, Human

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
To Compare the Effect of a Subcutaneous Canakinumab Administration to Placebo in Patients With Impaired Glucose Tolerance or Patients With Type 2 Diabetes With Differing Baseline Diabetes Therapies
Canakinumab 150 mg, Placebo to Canakinumab - Type 2 Diabetes Mellitus, Impaired Glucose Tolerance
Phase 2CompletedNovartis2462010-02-012011-09-05
Liquid Meal Study With Insulin Lispro With/Without Recombinant Human Hyaluronidase PH20 (rHuPH20) and Regular Human Insulin With rHuPH20 to Compare Pharmacokinetics, Postprandial Glycemic Response, and Optimal Insulin Dose in Participants With Type 2 Diabetes Mellitus (T2DM)
Humalog, Humulin-R, Recombinant human hyaluronidase PH20 (rHuPH20) - Diabetes Mellitus, Type 2
Phase 2CompletedHalozyme Therapeutics232009-07-012014-08-18
Phase II Pharmacokinetics Study of Humalog and Humulin-R With and Without rHuPH20 in Type 1 Diabetes Mellitus
Humalog, Humulin-R, Recombinant human hyaluronidase PH20 (rHuPH20) - Type 1 Diabetes Mellitus
Phase 2CompletedHalozyme Therapeutics222008-10-012019-02-26
Feasibility Study of the Effect of Intra-Dermal Insulin Injection on Blood Glucose Levels After Eating
Regular insulin (Humulin), Insulin lispro (Humalog) - Diabetes Mellitus, Type 1
Phase 2CompletedBecton, Dickinson and Company302007-09-012008-08-22
Effects of Pulsatile Intravenous (IV) Insulin on Wound Healing in Diabetics
Pulsatile Intravenous Insulin Therapy - Wound Healing, Diabetes
Phase 2 / Phase 3TerminatedFlorida Atlantic University1522006-01-012016-08-10
Effects of Pulsatile Intravenous Insulin Delivery on Diabetic Neuropathy in pATIENTS (Pts) With Type 1 and Type 2 Diabetes
Placebo, Pulsatile IV insulin delivery (humalog, humulin, novolog) - Diabetic Neuropathy
Phase 2 / Phase 3WithdrawnFlorida Atlantic University2005-02-012016-08-10
Effect of Pulsatile IV Insulin on Circulating Risk Markers of Vascular and Metabolic Complications in Pts With Diabetes
Effect of Pulsatile IV insulin on diabetic pt blood markers, Effect of Pulsatile IV Insulin on blood markers - Diabetes Mellitus
Phase 2 / Phase 3TerminatedFlorida Atlantic University1052005-02-012016-08-09
Effects of Pulsatile Insulin Delivery on Diabetic Neuropathy in Patients With Types 1 and 2 Diabetes Mellitus
Effect of Pulsatile IV insulin on diabetic neuropathy, Effect of Pulsatile IV Insulin on diabetic neuropathy - Diabetes Mellitus, With Complications
Phase 2 / Phase 3TerminatedFlorida Atlantic University1522004-02-012016-08-10
Clinical Effects of Pulsatile Insulin Delivery on Cognitive Function- Phase 1
Pulsatile IV insulin therapy, Effects of Pulsatile IV Insulin on Cognitive functions - Diabetes Mellitus
Phase 2 / Phase 3TerminatedFlorida Atlantic University752003-06-012016-08-10
Effect Pulsatile IV Insulin Therapy on the Quality of Life in Patients With Types 1 and 2 Diabetes
Effects of Pulsatile IV insulin on Diabetic Quality of Life - Diabetes Mellitus
Phase 2 / Phase 3TerminatedFlorida Atlantic University1522003-03-012016-08-10

Conditions studied

Diabetes Complications (5)  ·  Diabetes Mellitus (5)  ·  Hypoglycemia (5)  ·  Insulin Resistance (3)  ·  Diabetes Mellitus, Type 1 (2)  ·  Diabetes Mellitus, Type 2 (2)  ·  Diabetic Neuropathies (2)  ·  Glucose Intolerance (1)  ·  Metabolic Syndrome (1)

Sponsors

Florida Atlantic University (6)  ·  Halozyme Therapeutics (2)  ·  Becton, Dickinson and Company (1)  ·  Novartis (1)

Countries

United States (9)  ·  Germany (2)  ·  Australia (1)  ·  Canada (1)  ·  Finland (1)  ·  India (1)  ·  Italy (1)

Top investigators

Betty Tuller, PhD (3)  ·  Betty Tuller, Ph.D (2)  ·  Betty Tuller, Ph.D. (1)  ·  Christoph Kapitza, MD (1)  ·  Linda A Morrow, M.D. (1)  ·  Marcus Hompesch, M.D. (1)

Results publications

PMID 21273493, PMID 21355716, PMID 22136324